Medlab Clinical |
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 14 November 2026 at 4:12am | ||||
|
Market Cap (14-Nov) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
Intention to Grant EU Notice NanoCelle
MDC released this announcement to the ASX on 7 April 2021, 8:23. The announcement is marked as price sensitive, and is 2 page(s) in length and 198.02kb in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
At the date of this announcement, MDC was 0.002% short sold according to ASIC data. It was ranked the 607th most shorted stock on the ASX. It is now ranked as the 544th most shorted stock on the ASX with 0.017% of total shares short sold as of the latest reported data (31 August 2021).
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| Intention to Grant EU Notice NanoCelle | 7 April 2021, 8:23 |
| Executive and Management changes | 31 March 2021, 11:32 |
| Ceasing to be a substantial holder x 2 | 29 March 2021, 14:44 |
| Change in substantial holding | 29 March 2021, 14:41 |
If you were already registered, log in here.